Quasar Medical Expands Global CDMO Operations
Quasar Medical, a leader in the manufacturing of interventional and minimally invasive medical devices, recently made waves in the industry by enhancing its global Contract Development and Manufacturing Organization (CDMO) platform. This strategic move significantly broadens Quasar's end-to-end capabilities, ultimately increasing value for medical device OEMs and innovators.
Acquisition Details
Quasar Medical announced the successful completion of its acquisition of Nordson Corporation's design & development contract manufacturing businesses. This acquisition includes facilities located in key MedTech regions and greatly expands Quasar's operations.
Strategic Importance
The addition of these facilities marks a transformative step for Quasar, allowing the company to seamlessly offer customers a concept-to-commercialization journey. With nearly 200 new staff members joining the team, including skilled development engineers and technicians, the company aims to foster an environment of growth and innovation.
As Quasar Medical moves forward, the commitment to serving customers effectively remains at the forefront. CEO Alex Wallstein stated, "This strategic acquisition marks an exciting new chapter for Quasar and the customers we serve. By combining our manufacturing excellence with world-class design, development, and assembly expertise, we can expand our global reach and enhance our customer partnerships."
Facility Enhancements
The acquisition bolsters Quasar's global presence with two FDA-registered, ISO 13485-certified facilities. These facilities are positioned in vital markets, enabling improved access and proximity for customers. The Galway facility is set to become a hub for innovation in developing advanced medical device components, such as extrusions, braiding, and complex catheters, enhancing Quasar's design, prototyping, and clinical innovation capabilities.
Production Advancements
On the other hand, the Tecate facility will focus on high-volume manufacturing, establishing cost-effective solutions for transitioning from product development to commercialization. COO Aviel Bohnik remarked, "This is a pivotal milestone for Quasar, positioning us as a vital partner to our customers. With the addition of these facilities, we offer a differentiated platform that delivers innovation and speed to market, enhancing our overall operational excellence across regions."
Improving Customer Solutions
The integration of Nordson Medical's capabilities into Quasar’s global platform allows for a more seamless approach to developing complex interventional devices. This includes:
- Advanced product development and rapid prototyping in Galway
- Expertise in design-for-manufacturing, balloon catheter, and shaft development
- Manufacturing excellence in Tecate, including molding and packaging processes
This acquisition significantly enhances Quasar's cleanroom footprint, deepening expertise in crucial areas like extrusions and delivery systems, and providing ample room for growth at both new sites. The benefits for customers include improved access in global markets, faster development timelines, enhanced quality controls, and cost-effective production methods.
Commitment to Collaboration
Quasar is dedicated to working closely with Nordson during the transition, ensuring stability for employees, customers, and suppliers alike. The emphasis on collaboration aims to strengthen relationships, ensuring that the integration process runs smoothly and efficiently.
About Quasar Medical
Quasar Medical is a prominent Contract Development and Manufacturing Organization (CDMO) specializing in delivering comprehensive solutions for interventional and minimally invasive medical devices. With 11 facilities worldwide and a workforce exceeding 4,300 employees, Quasar is recognized for its capabilities in producing catheter systems, balloon technologies, micro-EM sensors, and complex assemblies. Headquartered in Singapore, the company prides itself on providing fully integrated device solutions, encompassing design, prototyping, and scalable manufacturing that adheres to the highest quality standards. Quasar Medical serves leading medical device OEMs and innovators, ensuring exceptional scalability and speed to market.
Frequently Asked Questions
What does Quasar Medical specialize in?
Quasar Medical specializes in the design, development, and manufacturing of interventional and minimally invasive medical devices.
What recent acquisition has Quasar Medical completed?
Quasar Medical recently acquired Nordson Corporation's manufacturing facilities in Galway and Tecate.
How does this acquisition benefit Quasar's operations?
The acquisition expands Quasar's capabilities, enhances product development, and improves manufacturing processes significantly.
What kind of facilities has Quasar acquired?
Quasar now operates two FDA-registered, ISO 13485-certified facilities that enhance its global presence in key MedTech regions.
What is Quasar's commitment following the acquisition?
Quasar is committed to ensuring a seamless transition for all stakeholders, including employees and customers, while fostering innovation and operational excellence.
